Shared microscope for cutting-edge biomedical imaging in Idaho
Official title: FLUOVIEW FV4000 Confocal Microscope for Biomedical Research in Idaho
Funded at Idaho State University · NIH-11366582 · Data updated 2026-11-12
A request to buy a high-end confocal microscope that will help scientists at Idaho State University and partner centers study aging, diabetes, and Alzheimer’s disease using detailed 3D images.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Idaho State University NIH-funded |
| Lab location | 1 site (Pocatello, United States) |
| Project start | September 1, 2026 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $249,779 |
| NIH project number | 1S10DE036801-01 |
| Project ID | NIH-11366582 on NIH RePORTER |
Who could benefit from this research
✓Could help
This grant is equipment-focused and does not involve enrolling patients directly; however, it supports research that may eventually lead to patient-focused breakthroughs.
✕Less likely to help
Direct patient participation is not part of this grant.
What this research studies
This grant funds a FV4000 Confocal Microscope to replace an older system and enable high-resolution, 3D imaging of cells in both fixed and live states. The new instrument will support a wide range of NIH- and NSF-funded projects and enhance education for undergraduate and graduate students through ISU programs. Researchers aim to explore how aging affects insulin secretion in type 2 diabetes and to identify genes involved in craniofacial development, among other biology projects. The equipment will also bolster teaching and collaboration across Idaho’s biomedical community.
Why it matters
Potential benefit: Patients could benefit indirectly through faster, more precise biological discoveries related to diabetes and neurodegenerative diseases.
How similar studies have gone: High-quality confocal imaging has consistently advanced understanding of cellular processes and disease mechanisms in similar settings.
Where this research is happening
-
Idaho State University
Pocatello, United States Active
Researchers
- Principal investigator: De la Cruz Ramirez, Lizbeth — Idaho State University
- Study coordinator: De la Cruz Ramirez, Lizbeth
Related research
Other NIH-funded projects on the same topics.
-
Broad CDK2/4/6 inhibitors to overcome resistance in cancer
A new set of selective CDK2/4/6 inhibitors will be explored to help patients whose cancers stop responding to current CDK4/6 therapies.
-
BRING-IT: Building Idaho State University’s Biomedical Research Capacity
A grant to help Idaho State University map its current research strengths and create a practical plan to grow biomedical research capacity for faculty and students.
-
Ceramide-based therapy targeting SMS1 to treat advanced prostate cancer
A new approach aims to slow or stop castration-resistant prostate cancer in men 65 and older by using molecules that mimic ceramide to block a key enzyme, potentially helping those whose cancer no longer responds to standard treatments.
-
Bone-targeted Ang1-7 for slowing breast cancer spread
A new treatment approach aims to deliver a cancer-fighting peptide directly to bone to help stop breast cancer from spreading, especially for hard-to-treat forms.
-
Using integral equations to map brain dynamics for better diagnosis
A machine-learning approach using nonlocal brain models aims to create continuous scores that reflect brain cognition and help diagnose cognitive disorders.
-
Grael 4K PSG/EEG instrument for sleep and brain research
A new high-definition PSG/EEG machine will help researchers at Idaho State University study sleep, brain activity, and behavior.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.